Ignite Creation Date:
2024-05-05 @ 11:03 PM
Last Modification Date:
2024-10-26 @ 10:28 AM
Study NCT ID:
NCT01245101
Status:
TERMINATED
Last Update Posted:
2016-12-23
First Post:
2010-11-19
Brief Title:
Addition of Raltegravir to Established Antiretroviral Suppressive Therapy
Sponsor:
University of Miami
Organization:
University of Miami
Organization Data
Organization:
University of Miami
Class:
OTHER
Study ID:
20100499
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Miami
Lead Sponsor Class:
OTHER
Responsible Party:
Rafael Campo
Responsible Party Title:
Professor of Clinical
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University of Miami
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Merck Sharp Dohme LLC | INDUSTRY |